Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02197429 · ClinicalTrials.gov registry record · NA

Acupuncture for the Treatment of Vulvodynia

A NA study of Pain and Dyspareunia, sponsored by Schlaeger, Judith M., CNM, LAc, PhD.

Completed
Registry status
NA
Development phase
36
Enrollment target
1
Study location

NCT02197429: Completed NA study of Pain and Dyspareunia, sponsored by Schlaeger, Judith M., CNM, LAc, PhD.

NCT02197429 is a NA study of Pain and Dyspareunia that has completed, run by Schlaeger, Judith M., CNM, LAc, PhD. The registered enrollment target is 36 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02197429, a NA study of Pain and Dyspareunia, has completed, sponsored by Schlaeger, Judith M., CNM, LAc, PhD.

COMPLETED
Registry status
NA
Development phase
36 participants
Enrollment target
1
Study location

Study Summary

A randomized controlled pilot study was conducted to evaluate the effect of an acupuncture protocol for the treatment of vulvodynia. Hypotheses: 1. Acupuncture reduces vulvar pain and dyspareunia in women with vulvodynia. 2. Acupuncture increases sexual function in women with vulvodynia.

Primary Outcome

Change from baseline in The Short Form McGill Pain Questionnaire at 5 weeks

Interventions

  • OTHER Acupuncture

Study Locations (1)

Illinois

  • Glenview Healing Arts - Glenview

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2012-02
Est. Completion 2012-12
Phase NA

What the finished NCT02197429 record still lists

NCT02197429 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 304-participant average among 374 other Pain trials with a reported enrollment target (88% lower).

The record links to 5 conditions, with Pain appearing as the primary indexed condition, and to 1 intervention - of which Acupuncture is the first listed.

NCT02197429 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT02197429 about?

NCT02197429 is a clinical study titled "Acupuncture for the Treatment of Vulvodynia". A randomized controlled pilot study was conducted to evaluate the effect of an acupuncture protocol for the treatment of vulvodynia. Hypotheses: 1. Acupuncture reduces vulvar pain and dyspareunia in women with vulvodynia. 2. Acupuncture increases sexual function in women with vulvodynia.

What is the current status of trial NCT02197429?

This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2012-02. Estimated completion is 2012-12.

What conditions does trial NCT02197429 study?

This clinical trial studies the following conditions: Pain, Dyspareunia, Vulvodynia, Vulvar Vestibulitis, Female Sexual Dysfunction Due to Physical Condition.

What interventions are being tested in trial NCT02197429?

The interventions under investigation include: Acupuncture (OTHER).

Who is sponsoring clinical trial NCT02197429?

This trial is sponsored by Schlaeger, Judith M., CNM, LAc, PhD, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02197429 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02197429's enrollment target sits among peer trials

36 296th of 374 higher than 77 of 374 other Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00929006 · 36 participants · Early Phase 1

    Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism

  • NCT01891318 · 36 participants · Phase 1

    Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study

  • NCT02291848 · 36 participants · Phase 1

    Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma

  • NCT02366819 · 36 participants · Phase 4

    Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02197429, the US trial registry maintained by the National Library of Medicine. NCT02197429 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.